Scientific conference
presentations
2020
European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer, virtual, 1–4 July 2020
- Oral (O-1): Ross P et al. PanCO: Updated results of an open-label, single-arm pilot study of OncoSil™ P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy
-
Poster (654): Allerdice S et al. Naïve indirect treatment comparison of PanCO, a pilot study of OncoSil™ P-32 microparticles combined with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy, versus standard-of-care treatment in unresectable locally advanced pancreatic cancer
2019
Video case report: Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience
American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA, 31 May –4 June 2019
Poster (4125): Ross, P et al. 2019. PanCO: An Open-Label, Single-Arm Pilot Study of Phosphorus-32 (P-32; OncoSil™) Microparticles in Patients with Unresectable Locally Advanced Pancreatic Adenocarcinoma (LAPC) in Combination with FOLFIRINOX or Gemcitabine + Nab-Paclitaxel (GNP) Chemotherapies
Australian and New Zealand Society of Nuclear Medicine (ANZNM) Annual Scientific Meeting, Adelaide, SA, 26–28 April 2019
Oral (O-35): Bartholomeusz D et al. Combined chemotherapy with endoscopic ultrasound (EUS) guided 32P OncoSil™ implantation for locally advanced pancreatic cancer: preliminary results from the Royal Adelaide Hospital (RAH)
2017
European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer, Barcelona, Spain, 28 June–1 July 2017
Poster (229-P): Ross, P et al. PanCO: An open label, single arm pilot study of OncoSil™ in subjects with unresectable locally advanced pancreatic adenocarcinoma, given in combination with standard chemotherapy
Other Publications
Bhutani MS et al. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: First united states experience. VideoGIE 2019; 4: 223–225.
OncoSil™ in pancreatic cancer
OncoSil™ has been studied in two clinical trials in unresectable locally advanced pancreatic cancer
OncoSil device
OncoSil™ is a single-use brachytherapy device
Getting started with OncoSil™
Learn how to get started with OncoSil™ in your institution